The Recall Desk
HighFDA (Drugs)·D-0017-2026·Announced 2025-10-22

[pending] ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)

Pending LLM rewrite. Source: FDA_DRUG D-0017-2026.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Pending LLM scoring against the rubric.

Plain-English summary

Failed Dissolution Specifications

The recalled product

Product
ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)
Brand
ATORVASTATIN CALCIUM
Manufacturer
Ascend Laboratories, LLC
Category
Drug — Drugs

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (9)

  • Lot#: 25141249
  • Exp. Feb. 2027 Lot#: 24144938
  • Exp. Nov. 2026 Lot#: 24144868
  • Exp. Nov. 2026 Lot#: 24144867
  • Exp. Nov. 2026 Lot#: 24144458
  • Exp. Sep. 2026 Lot#: 24143994
  • Exp. Sep. 2026 Lot#: 24142987
  • Exp. July 2026 Lot#: 24143316
  • Exp. July 2026

UPCs (3)

  • 0367877512051
  • 0367877513102
  • 0367877514109

Distribution

Distributed nationwide across the United States.

Related recalls

Same brand · ATORVASTATIN CALCIUM

Same category